Daclatasvir plus Peginterferon and Ribavirin is Non-inferior to Peginterferon and Ribavirin Alone, and Reduces Duration of Treatment for HCV Genotype 2 or 3 Infection: Chronic hepatitis C presenting with a diagnosis of hepatocellular carcinoma

Gregory J Dore, Eric Lawitz, Christophe Hézode, Stephen D Shafran, Alnoor Ramji, Harvey A Tatum, Gloria Taliani, Albert Tran, Maurizia R Brunetto, Serena Zaltron, Simone I Strasser, Nina Weis, Wayne Ghesquiere, Samuel S Lee, Dominique Larrey, Stanislas Pol, Hugh Harley, Jacob George, Scott Fung, Victor de LédinghenPeggy Hagens, Fiona McPhee, Dennis Hernandez, David Cohen, Elizabeth Cooney, Stephanie Noviello, Eric A Hughes

46 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Daclatasvir plus Peginterferon and Ribavirin is Non-inferior to Peginterferon and Ribavirin Alone, and Reduces Duration of Treatment for HCV Genotype 2 or 3 Infection: Chronic hepatitis C presenting with a diagnosis of hepatocellular carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences